A multicenter, randomized study of decitabine as epigenetic priming with induction chemotherapy in children with AML.

about

A phase 1 study of azacitidine combined with chemotherapy in childhood leukemia: a report from TACL consortium.

P2860

Q50020673-83C5ECED-F227-4375-AC2E-3B45FA22EC01

P2860

A multicenter, randomized study of decitabine as epigenetic priming with induction chemotherapy in children with AML.

Item

http://www.wikidata.org/entity/Q42371209

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

2017年论文

@zh

2017年论文

@zh-cn

name

A multicenter, randomized stud ...... otherapy in children with AML.

@en

A multicenter, randomized stud ...... otherapy in children with AML.

@nl

type

Item

label

A multicenter, randomized stud ...... otherapy in children with AML.

@en

A multicenter, randomized stud ...... otherapy in children with AML.

@nl

prefLabel

A multicenter, randomized stud ...... otherapy in children with AML.

@en

A multicenter, randomized stud ...... otherapy in children with AML.

@nl

P1476

A multicenter, randomized stud ...... otherapy in children with AML.

@en

P2093

Aru Narendran

http://www.w3.org/2001/XMLSchema#string

Bodour Salhia

http://www.w3.org/2001/XMLSchema#string

Carola Arndt

http://www.w3.org/2001/XMLSchema#string

Christophe Legendre

http://www.w3.org/2001/XMLSchema#string

Daniel Wai

http://www.w3.org/2001/XMLSchema#string

David Lee

http://www.w3.org/2001/XMLSchema#string

Frank Alvaro

http://www.w3.org/2001/XMLSchema#string

Gerald C Gooden

http://www.w3.org/2001/XMLSchema#string

Jessica Boklan

http://www.w3.org/2001/XMLSchema#string

Jessica Pollard

http://www.w3.org/2001/XMLSchema#string

P2860

Defining minimal residual disease in acute myeloid leukemia: which platforms are ready for "prime time"?

Outlier Analysis and Top Scoring Pair for Integrated Data Analysis and Biomarker Discovery.

Sensitization by 5-aza-2'-deoxycytidine of leukaemia cells with MLL abnormalities to induction of differentiation by all-trans retinoic acid and 1alpha,25-dihydroxyvitamin D3.

Genomewide DNA methylation analysis reveals novel targets for drug development in mantle cell lymphoma.

The landscape of somatic mutations in epigenetic regulators across 1,000 paediatric cancer genomes.

Results of a randomized study of 3 schedules of low-dose decitabine in higher-risk myelodysplastic syndrome and chronic myelomonocytic leukemia.

Phase I study of decitabine alone or in combination with valproic acid in acute myeloid leukemia.

Phase 1 study of epigenetic priming with decitabine prior to standard induction chemotherapy for patients with AML.

Transient low doses of DNA-demethylating agents exert durable antitumor effects on hematological and epithelial tumor cells.

Pathway Implications of Aberrant Global Methylation in Adrenocortical Cancer

P2888

s13148-017-0411-x

P304

108

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1186/S13148-017-0411-X

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Jason E Farrar

P577

2017-10-05T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1092106909

http://www.w3.org/2001/XMLSchema#string

P698

29034009

http://www.w3.org/2001/XMLSchema#string

P921

multicenter trial

P932

5629751

http://www.w3.org/2001/XMLSchema#string

A multicenter, randomized study of decitabine as epigenetic priming with induction chemotherapy in children with AML.

about

P2860

P2860

A multicenter, randomized study of decitabine as epigenetic priming with induction chemotherapy in children with AML.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P478

P50

P577

P6179

P698

P921

P932

P356

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P478

P50

P577

P6179

P698

P921

P932